Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

MINDY3 activates bortezomib. 1 / 1

| 1

➶

reach

"Since, CCAR1 and CARP -1 is an emerging and novel target of diverse cell growth and apoptosis signaling pathways [XREF_BIBR, XREF_BIBR - XREF_BIBR] and is not involved in cisplatin dependent HBC growth inhibition [XREF_BIBR], our identification of novel Velcade targets such as CCAR1 and CARP -1 has potential to allow for design of effective anti-MPM strategies for optimizing Velcade utility in a range of MPM including the drug (Cisplatin)-resistant phenotype."

19960346

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...